237 related articles for article (PubMed ID: 11278713)
1. Plasminogen activator inhibitor type 2 contains mRNA instability elements within exon 4 of the coding region. Sequence homology to coding region instability determinants in other mRNAs.
Tierney MJ; Medcalf RL
J Biol Chem; 2001 Apr; 276(17):13675-84. PubMed ID: 11278713
[TBL] [Abstract][Full Text] [Related]
2. Inherent instability of plasminogen activator inhibitor type 2 mRNA is regulated by tristetraprolin.
Yu H; Stasinopoulos S; Leedman P; Medcalf RL
J Biol Chem; 2003 Apr; 278(16):13912-8. PubMed ID: 12578825
[TBL] [Abstract][Full Text] [Related]
3. An AU-rich sequence in the 3'-UTR of plasminogen activator inhibitor type 2 (PAI-2) mRNA promotes PAI-2 mRNA decay and provides a binding site for nuclear HuR.
Maurer F; Tierney M; Medcalf RL
Nucleic Acids Res; 1999 Apr; 27(7):1664-73. PubMed ID: 10075998
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen activator inhibitor type 2 gene induction by tumor necrosis factor and phorbol ester involves transcriptional and post-transcriptional events. Identification of a functional nonameric AU-rich motif in the 3'-untranslated region.
Maurer F; Medcalf RL
J Biol Chem; 1996 Oct; 271(42):26074-80. PubMed ID: 8824249
[TBL] [Abstract][Full Text] [Related]
5. Antisense targeting of c-fos transcripts inhibits serum- and TGF-beta 1-stimulated PAI-1 gene expression and directed motility in renal epithelial cells.
Kutz SM; Providence KM; Higgins PJ
Cell Motil Cytoskeleton; 2001 Mar; 48(3):163-74. PubMed ID: 11223948
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen activator inhibitor type-2 (PAI-2) gene transcription requires a novel NF-kappaB-like transcriptional regulatory motif.
Mahony D; Kalionis B; Antalis TM
Eur J Biochem; 1999 Aug; 263(3):765-72. PubMed ID: 10469140
[TBL] [Abstract][Full Text] [Related]
7. Urokinase-mediated transactivation of the plasminogen activator inhibitor type 2 (PAI-2) gene promoter in HT-1080 cells utilises AP-1 binding sites and potentiates phorbol ester-mediated induction of endogenous PAI-2 mRNA.
Dear AE; Costa M; Medcalf RL
FEBS Lett; 1997 Feb; 402(2-3):265-72. PubMed ID: 9037208
[TBL] [Abstract][Full Text] [Related]
8. Functionally independent AU-rich sequence motifs regulate KC (CXCL1) mRNA.
Novotny M; Datta S; Biswas R; Hamilton T
J Biol Chem; 2005 Aug; 280(34):30166-74. PubMed ID: 15994316
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms governing tumor-necrosis-factor-mediated regulation of plasminogen-activator inhibitor type-2 gene expression.
Dear AE; Shen Y; Rüegg M; Medcalf RL
Eur J Biochem; 1996 Oct; 241(1):93-100. PubMed ID: 8898893
[TBL] [Abstract][Full Text] [Related]
10. CA repeats in the 3'-untranslated region of bcl-2 mRNA mediate constitutive decay of bcl-2 mRNA.
Lee JH; Jeon MH; Seo YJ; Lee YJ; Ko JH; Tsujimoto Y; Lee JH
J Biol Chem; 2004 Oct; 279(41):42758-64. PubMed ID: 15294893
[TBL] [Abstract][Full Text] [Related]
11. mRNA localization by a 145-nucleotide region of the c-fos 3'--untranslated region. Links to translation but not stability.
Dalgleish G; Veyrune JL; Blanchard JM; Hesketh J
J Biol Chem; 2001 Apr; 276(17):13593-9. PubMed ID: 11139568
[TBL] [Abstract][Full Text] [Related]
12. Two cellular proteins bind specifically to a purine-rich sequence necessary for the destabilization function of a c-fos protein-coding region determinant of mRNA instability.
Chen CY; You Y; Shyu AB
Mol Cell Biol; 1992 Dec; 12(12):5748-57. PubMed ID: 1448102
[TBL] [Abstract][Full Text] [Related]
13. Post-transcriptional regulation of plasminogen activator inhibitor type-1 expression in human pleural mesothelial cells.
Shetty S; Velusamy T; Shetty RS; Marudamuthu AS; Shetty SK; Florova G; Tucker T; Koenig K; Shetty P; Bhandary YP; Idell S
Am J Respir Cell Mol Biol; 2010 Sep; 43(3):358-67. PubMed ID: 19855086
[TBL] [Abstract][Full Text] [Related]
14. The plasminogen activator inhibitor 2 transcript is destabilized via a multi-component 3' UTR localized adenylate and uridylate-rich instability element in an analogous manner to cytokines and oncogenes.
Stasinopoulos S; Mariasegaram M; Gafforini C; Nagamine Y; Medcalf RL
FEBS J; 2010 Mar; 277(5):1331-44. PubMed ID: 20392207
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of cis-acting elements in the human and bovine PTH mRNA 3'-untranslated region.
Bell O; Silver J; Naveh-Many T
J Bone Miner Res; 2005 May; 20(5):858-66. PubMed ID: 15824859
[TBL] [Abstract][Full Text] [Related]
16. Identification of sequences in c-myc mRNA that regulate its steady-state levels.
Yeilding NM; Rehman MT; Lee WM
Mol Cell Biol; 1996 Jul; 16(7):3511-22. PubMed ID: 8668167
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the plasminogen activator inhibitor type-2 gene in monocytes: localization of an upstream transcriptional silencer.
Antalis TM; Costelloe E; Muddiman J; Ogbourne S; Donnan K
Blood; 1996 Nov; 88(10):3686-97. PubMed ID: 8916932
[TBL] [Abstract][Full Text] [Related]
18. A constitutive decay element promotes tumor necrosis factor alpha mRNA degradation via an AU-rich element-independent pathway.
Stoecklin G; Lu M; Rattenbacher B; Moroni C
Mol Cell Biol; 2003 May; 23(10):3506-15. PubMed ID: 12724409
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel AU-Rich element in the 3' untranslated region of epidermal growth factor receptor mRNA that is the target for regulated RNA-binding proteins.
Balmer LA; Beveridge DJ; Jazayeri JA; Thomson AM; Walker CE; Leedman PJ
Mol Cell Biol; 2001 Mar; 21(6):2070-84. PubMed ID: 11238942
[TBL] [Abstract][Full Text] [Related]
20. Identification of a C-terminal tripeptide motif involved in the control of rapid proteasomal degradation of c-Fos proto-oncoprotein during the G(0)-to-S phase transition.
Acquaviva C; Brockly F; Ferrara P; Bossis G; Salvat C; Jariel-Encontre I; Piechaczyk M
Oncogene; 2001 Nov; 20(51):7563-72. PubMed ID: 11709728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
